Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 4,225 shares at $58.00 ($240K) on 2025-02-13, disclosed to the SEC on 2025-02-14.
Scheduled sale ($240k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.39 | 600 | $34K | 14.1% |
| 2 | $56.39 | 1,205 | $68K | 28.3% |
| 3 | $56.39 | 1,205 | $68K | 28.3% |
| 4 | $56.41 | 10 | $564 | 0.2% |
| 5 | $58.00 | 1,205 | $70K | 29.1% |
| Total | $56.85 avg | 4,225 |
| $240K |
| 100% |
| Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |
| RYTM | SELL | 2025-02-04 | $172K | — | Filing → |